| Dora Anexi Aguayo, PHARMD | |
|
777 N Raymond St, Boise, ID 83704-9251 | |
| (208) 514-2500 | |
| Not Available |
| Full Name | Dora Anexi Aguayo |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 777 N Raymond St, Boise, Idaho |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1245965987 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | P10091 (Idaho) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dora Anexi Aguayo, PHARMD 1535 W Dakota Loop, Nampa, ID 83686-9701 Ph: () - | Dora Anexi Aguayo, PHARMD 777 N Raymond St, Boise, ID 83704-9251 Ph: (208) 514-2500 |
News Archive
University Hospitals Case Medical Center will begin a Phase 1 clinical trial on a new experimental anti-tuberculosis drug called TMC207.
Tandem Diabetes Care, Inc. , a medical device company and manufacturer of the only touchscreen insulin pumps with continuous glucose monitoring (CGM) integration, today announced its launch of the t:slim X2 Insulin Pump with Basal-IQ™ Technology, a predictive low glucose suspend (PLGS) feature designed to help reduce the frequency and duration of low glucose events (hypoglycemia).
A study carried out by the Institute of Environmental Science and Technology of the Universitat Autònoma de Barcelona and the Instituto de Saúde Pública of the University of Porto, concludes that exposure to natural spaces during the first COVID-19 lockdown in 2020 was beneficial for the mental health of Spanish and Portuguese citizens.
Health care providers and human service agencies often manage postpartum depression with formal mental health treatments and antidepressant therapies, but for new, low-income mothers of color these interventions often provide little relief from the mood disorder that sometimes follows childbirth, according to a new study led by a University at Buffalo researcher.
Findings from Canadian Prostate Cancer Genome Network (CPC-GENE) researchers and their collaborators, published today in Cell, show that the aggressiveness of an individual prostate cancer can be accurately assessed by looking at how that tumor has evolved. This information can be used to determine what type and how much treatment should be given to each patient, or if any is needed at all.
› Verified 9 days ago
Eleanor I Evans, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5005 W Overland Rd, Boise, ID 83705 Phone: 208-389-1448 Fax: 208-389-1458 | |
Ms. Fatima Walizada, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5005 W Overland Rd, Boise, ID 83705 Phone: 208-389-1448 | |
David Lyn Harrison, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 9196 W Emerald St, Suite 110, Boise, ID 83704 Phone: 208-323-1259 Fax: 208-323-5666 | |
Mary Gobeille, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5230 W Franklin Rd, Boise, ID 83705 Phone: 208-429-6433 | |
Megan B Seewald, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3233 N Cole Rd, Boise, ID 83704 Phone: 208-501-7032 Fax: 208-501-7026 | |
Dr. Christopher K Johnson, PHARM.D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3232 Elder Street, Boise, ID 83705 Phone: 208-364-1829 Fax: 180-032-7554 | |
Dr. Catherine M Oliphant, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 300 E Jefferson St, Suite 201, Boise, ID 83712 Phone: 208-381-4146 Fax: 208-381-1665 |